Occurrence, regulation, and significance of progesterone receptors in human meningioma.
The abundant expression of progesterone receptors (PR) in human meningiomas is well established. It is unknown, however, how PR expression is regulated, especially since estrogen receptors (ER) are virtually absent in these tumors. At the mRNA level, ER splice variants occur in meningioma but these appear not to be involved in the apparently autonomous PR expression. In an earlier study, because other ER-inducible proteins were either not expressed at all (pS2) or were expressed at a very low level compared to their expression in breast cancer (Cathepsin-D), the authors have postulated that the autonomous PR expression in meningioma is PR promoter-related rather than ER-related and have studied PR expression in cultured meningioma cells. PR levels appeared to decrease rapidly in vitro in monolayer as well as in three dimensional spheroid cultures. Culture conditions thus are not yet sufficient for the quantitative evaluation of PR expression. To evaluate whether PR deterioration is associated with cell turnover (meningiomas grow much faster in vitro than in vivo), the relationship between expression of the apoptotic proteins Bcl-2 and Bax and PR expression was investigated. Bcl-2 expression was found to be highest in meningioma with low PR levels, and in breast cancer tissue with high PR levels. Bax expression was not related to PR expression in any of the two tissues. Given the potential benefit of antiprogestin treatment and the occurrence in meningiomas of a protein capable of binding to the estrogen-responsive element, the expression of PR in meningioma remains a fascinating phenomenon which requires further investigation.
Blankenstein
M A
MA
Department of Endocrinology, KE 03_139.2, University Medical Center Utrecht, P.O. Box 85090, NL 3508 AB, Utrecht, The Netherlands. m.a.blankenstein@lab.azu.nl
Verheijen
F M
FM
Jacobs
J M
JM
Donker
T H
TH
van Duijnhoven
M W
MW
Thijssen
J H
JH
D005260:Female; D006801:Humans; D008577:Meningeal Neoplasms / Q000378:metabolism / Q000473:pathology; D008579:Meningioma / Q000378:metabolism* / Q000473:pathology; D011980:Receptors, Progesterone / Q000235:genetics / Q000378:metabolism* / Q000502:physiology
D011980:Receptors, Progesterone